For instance, Jones et al., 2021 [28] developed the PRecur model, a gradient-boosted machine learning framework that combines clinicopathologic variables such as the tumor size and histological subtype with genomic data like TP53 and SMARCA4 mutations. This evidence concerns the gene TP53 and neoplasm.